Kalon Biotherapeutics will manufacture medical countermeasures under a contract awarded to The Texas A&M University System to develop one of three US Department of Health and Human Services Centers for Innovation in Advanced Development and Manufacturing.
Kalon Biotherapeutics
Wednesday 20 June 2012
Kalon to manufacture countermeasures
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment